Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety (Q35681023)
Jump to navigation
Jump to search
scientific article published on February 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety |
scientific article published on February 2012 |
Statements
1 reference
Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% StarPharma LTD 7013 gel (VivaGel) to assess expanded safety (English)
1 reference
Elizabeth A Bukusi
1 reference
Craig R Cohen
1 reference
Rupert Kaul
1 reference
Anna-Barbara Moscicki
1 reference
Yifei Ma
1 reference
Mark E Scott
1 reference
Ibrahim I Daud
1 reference
Stephen Shiboski
1 reference
Anuradha Rebbapragada
1 reference
Sanja Huibner
1 reference
1 February 2012
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference